Acute effects of transdermal estrogen on hemodynamic and vascular reactivity in elderly postmenopausal healthy women

Journal of Hypertension

Volumn 21, Issue 2, 2003, Pages 387-394

  Manhem, Karin ^a   Brandin, Lisa ^a   Ghanoum, Bachar ^a   Rosengren, Annika ^a   Gustafsson, Helena ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure; Estrogen; Heart rate; Postmenopausal women; Resistance arteries

Indexed keywords

ACETYLCHOLINE; ADRENALIN; ESTRADIOL; ESTROGEN; MUSCARINIC RECEPTOR; NITRIC OXIDE; NORADRENALIN; PLACEBO; PROSTANOID; SUBSTANCE P;

ADULT; ARTERY CONSTRICTION; ARTICLE; BIOPSY; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BLOOD VESSEL REACTIVITY; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPOLARIZATION; DIASTOLIC BLOOD PRESSURE; DOSE CALCULATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEALTH STATUS; HEART BEAT; HEART RATE; HEMODYNAMICS; HORMONAL THERAPY; HUMAN; HYPERPOLARIZATION; MENTAL STRESS; NORMAL HUMAN; PERIPHERAL CIRCULATION; PILOT STUDY; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TIME;

EID: 0037332163     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200302000-00031     Document Type: Article

References (35)

1. Staessen J, Bulpitt CJ, Fagard R, Lijmem P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens 1989; 3:427-433.
2. Portaluppi F, Pansini F, Manfredini R, Mollica G. Relative influence of menopauseal status, age, and body mass index on blood pressure. Hypertension 1997; 29:976-979.
3. Seely EW, Walsh BW, Gerhars MD, Williams GH. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension 1999; 3:1190-1194.
4. van Ittersum FJ, van Baal WM, Kenemans P, Mijatovic V, Donker ABJM, van der Mooren MJ, Stehouwer CDA. Ambulatory-not office-blood pressures decline during hormone replacement therapy in healthy postmenopausal women. Am J Hypertens 1998; 11:1147-1152.
5. Lip GY, Beevers M, Churchill D, Beevers DG. Hormone replacement therapy and blood pressure in hypertensive women. J Hum Hypertens 1994; 8:491-494.
6. Mercuro G, Pitzalis L, Podda A, Zoncu S, Pilia I, Melis GB, Cherchi A. Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women. Am J Cardiol 1999; 84:214-218.
7. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90:786-791.
8. Sudhir K, Esler M, Jennings G, Komesaroff P. Estrogen supplementation decreases norephinephrine-induced vasoconstriction and total body norephinephrine spillover in perimenopausal women. Hypertension 1997; 30:1538-1543.
9. Sung B, Ching M, Izzo J, Dandona P, Wilson M. Estrogen improves abnormal norephinephrine-induced vasoconstriction in postmenopausal women. J Hypertens 1999; 17:523-528.
10. Vongpatanasin W, Tuncel M, Mansour Y, Arbique D, Victor RG. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 2001; 103:2903-2908.
11. Delaney JPA, Brodie DA. Effects of short-term physiological stress on the time and frequency domains of heart-rate variability. Percept Mot Skills 2000; 91:515-524.
12. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41:19-26.
13. Hinojosa-Laborde C, Chapa I, Lange D, Haywood JR. Gender differences in sympathetic nervous system regulation. Clin Exp Pharmacol Physiol 1999; 26:122-126.
14. Roberts JM, Goldfien RD, Tsuchiya AM, Goldfien A, Insel PA. Estrogen treatment decreases alpha-adrenergic binding sites on rabbit platelets. Endocrinology 1079; 104:722-728.
15. Altura BM. Sex and estrogens and responsivness of terminal arterioles to neurohypophyseal hormones and catecholamines. J Pharmacol Exp Ther 1975; 193:403-412.
16. Rosano GM, Patrizi R, Leonardo F, Ponokowski P, Collins P, Sarrel PM, Chierchia SL. Effect of estrogen replacement theraphy on heart rate variability and heart rate in healthy postmenopausal women. Am J Cardiol 1997; 80:815-817.
17. Weitz G, Elam M, Born J, Fehm HL, Dodt C. Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity. J Clin Endocrinol Metab 2001; 86:344-348.
18. Del Rio G, Velardo A, Zizzo G, Avogaro A, Cipolli C, Della Casa I, Marrama P. Effect of estradiol on the sympathoadrenal response to mental stress in men. J Clin Endocrinol Metab 1994; 79:836-840.
19. Mezzacappa SE, Kelsey RM, Katkin ES, Sloan RP. Vagal rebound and recovery from psychological stress. Psychosomat Med 2001; 63:650-657.
20. Burleson MH, Malarkey WB, Cacioppo, JT, Poehlmann KM, Kiecolt-Glaser JK, Berntson GG, et al. Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief physiological stressors. Psychosomat Med 1998; 60:17-25.
21. Huikuri HV, Pikkujamsa SM, Airaksinen KE, Ikaheimo MJ, Rantala AO, Kauma P, et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation 1996; 15:122-125.
22. Barnett SR, Morin RJ, Kiely DK, Gagnon M, Azhar G, Knight EL, et al. Effects of age and gender on autonomic control of blood pressure dynamics. Hypertension 1999; 33:1195-1200.
23. Ul'yaninskii LS. Emotional stress and extracardiac regulation. Neurosci Behav Physiol 1995; 25:257-265.
24. Parati G. Obesity, hypertension and the sympathetic nervous system. J Hypertens 2002; 20:835-837.
25. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progesteron regimens on heart disease in postmenopausal women. JAMA 1995; 273:199-208.
26. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998; 280:605-613.
27. Light KC, Hinderliter AL, West SG, Grewen KM, Steege JF, Sherwood A, Girdler SS. Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women. J Hypertens 2001; 19:269-278.
28. Mercuro G, Zoncu S, Piano D, Pilia I, Lao A, Melis GB, Cherchi A. Estradiol-17 beta reduces blood pressre and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998; 11:909-913.
29. Manhem K, Ahlm H, Milsom I, Svensson A. Transdermal estrogen reduces daytime blood pressure in hypertensive women. J Hum Hypertens 1998; 12:323-327.
30. Magness RR, Rosenfeld CR. Local and systemic estradiol-17β effects on uterine and systemic vasidilation. Am J Physiol 1989; 257:E536-E542.
31. Komesaroff PA, Black CV, Westerman RA. A novel, nongenomic action of estrogen on the cardiovascular system. J Clin Endocrinol Metab 1998; 83:2313-2316.
32. Collins P, Rosano GM, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet 1993; 341:1264-1265.
33. Buus NH, Simonsen U, Pilegard HK, Mulvany MJ. Nitric oxide, prostanoid and non-NO, non-prostanoid involved in acetylcholine relaxation of isolated human small arteries. Br J Pharmacol 2000; 129:184-192.
34. Cheng DY, Feng CJ, Kadewitz PJ, Gruette CA. Effects of 17-β-estradiol on endothelium-dependent relaxation induced by acetylcholine in female rat aorta. Life Sci 1994; 55:187-191.
35. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988; 244:19-22.